APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non - Laboratory - based Cannabis Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non - Laboratory - based Cannabis Testing Market Analysis and Forecast 2026-2032

6 June 2026181 pages

Choose your research edition.

Industry ResearchNon - Laboratory - based Cannabis Testing Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Non - Laboratory - based Cannabis Testing Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Non - Laboratory - based Cannabis Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non - Laboratory - based Cannabis Testing Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Non - Laboratory - based Cannabis Testing Market Analysis and Forecast 2026-2032181 pages · $4,950 USD

Market perspective

The global Non - Laboratory - based Cannabis Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Non - Laboratory - based Cannabis Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Non - Laboratory - based Cannabis Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Non - Laboratory - based Cannabis Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Non - Laboratory - based Cannabis Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Non - Laboratory - based Cannabis Testing include Purpl Scientific, Orange Photonics, Inc., MyDx, Inc., tCheck, ALPHA—CAT and Sage Analytics, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Non - Laboratory - based Cannabis Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non - Laboratory - based Cannabis Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Non - Laboratory - based Cannabis Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non - Laboratory - based Cannabis Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non - Laboratory - based Cannabis Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Non - Laboratory - based Cannabis Testing revenue, projected growth trends, production technology, application and end-user industry.

Non - Laboratory - based Cannabis Testing Segment by Company

Purpl Scientific

Orange Photonics, Inc.

MyDx, Inc.

tCheck

ALPHA—CAT

Sage Analytics, Inc.

Non - Laboratory - based Cannabis Testing Segment by Type

Chromatography

Spectroscopy

Others

Non - Laboratory - based Cannabis Testing Segment by Application

Recreation

Agriculture

Others

Non - Laboratory - based Cannabis Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non - Laboratory - based Cannabis Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non - Laboratory - based Cannabis Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non - Laboratory - based Cannabis Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Non - Laboratory - based Cannabis Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Non - Laboratory - based Cannabis Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non - Laboratory - based Cannabis Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non - Laboratory - based Cannabis Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Chromatography Major Player Table 3. Spectroscopy Major Player Table 4. Others Major Player Table 5. Global Non - Laboratory - based Cannabis Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Recreation Major Player Table 7. Agriculture Major Player Table 8. Others Major Player Table 9. Non - Laboratory - based Cannabis Testing Industry Trends Table 10. Non - Laboratory - based Cannabis Testing Industry Drivers Table 11. Non - Laboratory - based Cannabis Testing Industry Opportunities and Challenges Table 12. Non - Laboratory - based Cannabis Testing Industry Restraints Table 13. Global Non - Laboratory - based Cannabis Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Non - Laboratory - based Cannabis Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Non - Laboratory - based Cannabis Testing Market Share by Region (2021-2026) Table 16. Global Non - Laboratory - based Cannabis Testing Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Non - Laboratory - based Cannabis Testing Market Share by Region (2027-2032) Table 18. Global Non - Laboratory - based Cannabis Testing Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Non - Laboratory - based Cannabis Testing Revenue Market Share by Players (2021-2026) Table 20. Global Non - Laboratory - based Cannabis Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Non - Laboratory - based Cannabis Testing Key Players Headquarters & Area Served Table 22. Global Non - Laboratory - based Cannabis Testing Players, Product Type & Application Table 23. Global Non - Laboratory - based Cannabis Testing Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Non - Laboratory - based Cannabis Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Non - Laboratory - based Cannabis Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Non - Laboratory - based Cannabis Testing Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Non - Laboratory - based Cannabis Testing Revenue Market Share by Type (2021-2026) Table 30. Global Non - Laboratory - based Cannabis Testing Revenue Market Share by Type (2027-2032) Table 31. Global Non - Laboratory - based Cannabis Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Non - Laboratory - based Cannabis Testing Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Non - Laboratory - based Cannabis Testing Revenue Market Share by Application (2021-2026) Table 35. Global Non - Laboratory - based Cannabis Testing Revenue Market Share by Application (2027-2032) Table 36. Purpl Scientific Company Information Table 37. Purpl Scientific Business Overview Table 38. Purpl Scientific Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Purpl Scientific Non - Laboratory - based Cannabis Testing Product Portfolio Table 40. Purpl Scientific Recent Development Table 41. Orange Photonics, Inc. Company Information Table 42. Orange Photonics, Inc. Business Overview Table 43. Orange Photonics, Inc. Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Orange Photonics, Inc. Non - Laboratory - based Cannabis Testing Product Portfolio Table 45. Orange Photonics, Inc. Recent Development Table 46. MyDx, Inc. Company Information Table 47. MyDx, Inc. Business Overview Table 48. MyDx, Inc. Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. MyDx, Inc. Non - Laboratory - based Cannabis Testing Product Portfolio Table 50. MyDx, Inc. Recent Development Table 51. tCheck Company Information Table 52. tCheck Business Overview Table 53. tCheck Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. tCheck Non - Laboratory - based Cannabis Testing Product Portfolio Table 55. tCheck Recent Development Table 56. ALPHA—CAT Company Information Table 57. ALPHA—CAT Business Overview Table 58. ALPHA—CAT Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. ALPHA—CAT Non - Laboratory - based Cannabis Testing Product Portfolio Table 60. ALPHA—CAT Recent Development Table 61. Sage Analytics, Inc. Company Information Table 62. Sage Analytics, Inc. Business Overview Table 63. Sage Analytics, Inc. Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Sage Analytics, Inc. Non - Laboratory - based Cannabis Testing Product Portfolio Table 65. Sage Analytics, Inc. Recent Development Table 66. North America Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2026) & (US$ Million) Table 67. North America Non - Laboratory - based Cannabis Testing Revenue by Type (2027-2032) & (US$ Million) Table 68. North America Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2026) & (US$ Million) Table 69. North America Non - Laboratory - based Cannabis Testing Revenue by Application (2027-2032) & (US$ Million) Table 70. North America Non - Laboratory - based Cannabis Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 71. North America Non - Laboratory - based Cannabis Testing Revenue by Country (2021-2026) & (US$ Million) Table 72. North America Non - Laboratory - based Cannabis Testing Revenue by Country (US$ Million) & (2027-2032) Table 73. Europe Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2026) & (US$ Million) Table 74. Europe Non - Laboratory - based Cannabis Testing Revenue by Type (2027-2032) & (US$ Million) Table 75. Europe Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2026) & (US$ Million) Table 76. Europe Non - Laboratory - based Cannabis Testing Revenue by Application (2027-2032) & (US$ Million) Table 77. Europe Non - Laboratory - based Cannabis Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 78. Europe Non - Laboratory - based Cannabis Testing Revenue by Country (2021-2026) & (US$ Million) Table 79. Europe Non - Laboratory - based Cannabis Testing Revenue by Country (US$ Million) & (2027-2032) Table 80. China Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2026) & (US$ Million) Table 81. China Non - Laboratory - based Cannabis Testing Revenue by Type (2027-2032) & (US$ Million) Table 82. China Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2026) & (US$ Million) Table 83. China Non - Laboratory - based Cannabis Testing Revenue by Application (2027-2032) & (US$ Million) Table 84. Asia Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2026) & (US$ Million) Table 85. Asia Non - Laboratory - based Cannabis Testing Revenue by Type (2027-2032) & (US$ Million) Table 86. Asia Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2026) & (US$ Million) Table 87. Asia Non - Laboratory - based Cannabis Testing Revenue by Application (2027-2032) & (US$ Million) Table 88. Asia Non - Laboratory - based Cannabis Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Asia Non - Laboratory - based Cannabis Testing Revenue by Region (US$ Million) & (2021-2026) Table 90. Asia Non - Laboratory - based Cannabis Testing Revenue by Region (US$ Million) & (2027-2032) Table 91. SAMEA Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2026) & (US$ Million) Table 92. SAMEA Non - Laboratory - based Cannabis Testing Revenue by Type (2027-2032) & (US$ Million) Table 93. SAMEA Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2026) & (US$ Million) Table 94. SAMEA Non - Laboratory - based Cannabis Testing Revenue by Application (2027-2032) & (US$ Million) Table 95. SAMEA Non - Laboratory - based Cannabis Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. SAMEA Non - Laboratory - based Cannabis Testing Revenue by Country (2021-2026) & (US$ Million) Table 97. SAMEA Non - Laboratory - based Cannabis Testing Revenue by Country (US$ Million) & (2027-2032) Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Non - Laboratory - based Cannabis Testing Image Figure 2. Global Non - Laboratory - based Cannabis Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non - Laboratory - based Cannabis Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Chromatography Image Figure 5. Spectroscopy Image Figure 6. Others Image Figure 7. Global Non - Laboratory - based Cannabis Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Non - Laboratory - based Cannabis Testing Market Size Share 2021 VS 2025 VS 2032 Figure 9. Recreation Image Figure 10. Agriculture Image Figure 11. Others Image Figure 12. Global Non - Laboratory - based Cannabis Testing Market Size (US$ Million) & (2021-2032) Figure 13. Global Non - Laboratory - based Cannabis Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Non - Laboratory - based Cannabis Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Non - Laboratory - based Cannabis Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Non - Laboratory - based Cannabis Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Non - Laboratory - based Cannabis Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Non - Laboratory - based Cannabis Testing Revenue Market Share by Type (2021-2032) Figure 20. Global Non - Laboratory - based Cannabis Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Non - Laboratory - based Cannabis Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Non - Laboratory - based Cannabis Testing Revenue Market Share by Application (2021-2032) Figure 23. North America Non - Laboratory - based Cannabis Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Non - Laboratory - based Cannabis Testing Revenue Share by Type (2021-2032) Figure 25. North America Non - Laboratory - based Cannabis Testing Revenue Share by Application (2021-2032) Figure 26. North America Non - Laboratory - based Cannabis Testing Revenue Share by Country (2021-2032) Figure 27. United States Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Non - Laboratory - based Cannabis Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Non - Laboratory - based Cannabis Testing Revenue Share by Type (2021-2032) Figure 32. Europe Non - Laboratory - based Cannabis Testing Revenue Share by Application (2021-2032) Figure 33. Europe Non - Laboratory - based Cannabis Testing Revenue Share by Country (2021-2032) Figure 34. Germany Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Non - Laboratory - based Cannabis Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Non - Laboratory - based Cannabis Testing Revenue Share by Type (2021-2032) Figure 44. China Non - Laboratory - based Cannabis Testing Revenue Share by Application (2021-2032) Figure 45. Asia Non - Laboratory - based Cannabis Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Non - Laboratory - based Cannabis Testing Revenue Share by Type (2021-2032) Figure 47. Asia Non - Laboratory - based Cannabis Testing Revenue Share by Application (2021-2032) Figure 48. Asia Non - Laboratory - based Cannabis Testing Revenue Share by Region (2021-2032) Figure 49. Japan Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Non - Laboratory - based Cannabis Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Non - Laboratory - based Cannabis Testing Revenue Share by Type (2021-2032) Figure 57. SAMEA Non - Laboratory - based Cannabis Testing Revenue Share by Application (2021-2032) Figure 58. SAMEA Non - Laboratory - based Cannabis Testing Revenue Share by Country (2021-2032) Figure 59. Brazil Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Non - Laboratory - based Cannabis Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Chromatography
  • Spectroscopy
  • Others
Applications
  • Recreation
  • Agriculture
  • Others
Companies covered
  • Purpl Scientific
  • Orange Photonics, Inc.
  • MyDx, Inc.
  • tCheck
  • ALPHA—CAT
  • Sage Analytics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non - Laboratory - based Cannabis Testing Market by Type
  3. 1.2.1 Global Non - Laboratory - based Cannabis Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Chromatography
  5. 1.2.3 Spectroscopy
  6. 1.2.4 Others
  7. 1.3 Non - Laboratory - based Cannabis Testing Market by Application
  8. 1.3.1 Global Non - Laboratory - based Cannabis Testing Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Recreation
  10. 1.3.3 Agriculture
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Non - Laboratory - based Cannabis Testing Market Dynamics
  1. 2.1 Non - Laboratory - based Cannabis Testing Industry Trends
  2. 2.2 Non - Laboratory - based Cannabis Testing Industry Drivers
  3. 2.3 Non - Laboratory - based Cannabis Testing Industry Opportunities and Challenges
  4. 2.4 Non - Laboratory - based Cannabis Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Non - Laboratory - based Cannabis Testing Market Perspective (2021-2032)
  2. 3.2 Global Non - Laboratory - based Cannabis Testing Growth Trends by Region
  3. 3.2.1 Global Non - Laboratory - based Cannabis Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Non - Laboratory - based Cannabis Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Non - Laboratory - based Cannabis Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Non - Laboratory - based Cannabis Testing Revenue by Players
  2. 4.1.1 Global Non - Laboratory - based Cannabis Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Non - Laboratory - based Cannabis Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Non - Laboratory - based Cannabis Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Non - Laboratory - based Cannabis Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Non - Laboratory - based Cannabis Testing Key Players Headquarters & Area Served
  7. 4.4 Global Non - Laboratory - based Cannabis Testing Players, Product Type & Application
  8. 4.5 Global Non - Laboratory - based Cannabis Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Non - Laboratory - based Cannabis Testing Market CR5 and HHI
  11. 4.6.3 2025 Non - Laboratory - based Cannabis Testing Tier 1, Tier 2, and Tier 3
5 Non - Laboratory - based Cannabis Testing Market Size by Type
  1. 5.1 Global Non - Laboratory - based Cannabis Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2032)
  3. 5.3 Global Non - Laboratory - based Cannabis Testing Revenue Market Share by Type (2021-2032)
6 Non - Laboratory - based Cannabis Testing Market Size by Application
  1. 6.1 Global Non - Laboratory - based Cannabis Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2032)
  3. 6.3 Global Non - Laboratory - based Cannabis Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Purpl Scientific
  2. 7.1.1 Purpl Scientific Company Information
  3. 7.1.2 Purpl Scientific Business Overview
  4. 7.1.3 Purpl Scientific Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Purpl Scientific Non - Laboratory - based Cannabis Testing Product Portfolio
  6. 7.1.5 Purpl Scientific Recent Developments
  7. 7.2 Orange Photonics, Inc.
  8. 7.2.1 Orange Photonics, Inc. Company Information
  9. 7.2.2 Orange Photonics, Inc. Business Overview
  10. 7.2.3 Orange Photonics, Inc. Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Orange Photonics, Inc. Non - Laboratory - based Cannabis Testing Product Portfolio
  12. 7.2.5 Orange Photonics, Inc. Recent Developments
  13. 7.3 MyDx, Inc.
  14. 7.3.1 MyDx, Inc. Company Information
  15. 7.3.2 MyDx, Inc. Business Overview
  16. 7.3.3 MyDx, Inc. Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 MyDx, Inc. Non - Laboratory - based Cannabis Testing Product Portfolio
  18. 7.3.5 MyDx, Inc. Recent Developments
  19. 7.4 tCheck
  20. 7.4.1 tCheck Company Information
  21. 7.4.2 tCheck Business Overview
  22. 7.4.3 tCheck Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 tCheck Non - Laboratory - based Cannabis Testing Product Portfolio
  24. 7.4.5 tCheck Recent Developments
  25. 7.5 ALPHA—CAT
  26. 7.5.1 ALPHA—CAT Company Information
  27. 7.5.2 ALPHA—CAT Business Overview
  28. 7.5.3 ALPHA—CAT Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 ALPHA—CAT Non - Laboratory - based Cannabis Testing Product Portfolio
  30. 7.5.5 ALPHA—CAT Recent Developments
  31. 7.6 Sage Analytics, Inc.
  32. 7.6.1 Sage Analytics, Inc. Company Information
  33. 7.6.2 Sage Analytics, Inc. Business Overview
  34. 7.6.3 Sage Analytics, Inc. Non - Laboratory - based Cannabis Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sage Analytics, Inc. Non - Laboratory - based Cannabis Testing Product Portfolio
  36. 7.6.5 Sage Analytics, Inc. Recent Developments
8 North America
  1. 8.1 North America Non - Laboratory - based Cannabis Testing Revenue (2021-2032)
  2. 8.2 North America Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Non - Laboratory - based Cannabis Testing Revenue by Type (2027-2032)
  5. 8.3 North America Non - Laboratory - based Cannabis Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Non - Laboratory - based Cannabis Testing Revenue by Application (2027-2032)
  9. 8.5 North America Non - Laboratory - based Cannabis Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Non - Laboratory - based Cannabis Testing Revenue by Country
  11. 8.6.1 North America Non - Laboratory - based Cannabis Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Non - Laboratory - based Cannabis Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Non - Laboratory - based Cannabis Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Non - Laboratory - based Cannabis Testing Revenue (2021-2032)
  2. 9.2 Europe Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Non - Laboratory - based Cannabis Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Non - Laboratory - based Cannabis Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Non - Laboratory - based Cannabis Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Non - Laboratory - based Cannabis Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Non - Laboratory - based Cannabis Testing Revenue by Country
  11. 9.6.1 Europe Non - Laboratory - based Cannabis Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Non - Laboratory - based Cannabis Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Non - Laboratory - based Cannabis Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Non - Laboratory - based Cannabis Testing Revenue (2021-2032)
  2. 10.2 China Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Non - Laboratory - based Cannabis Testing Revenue by Type (2027-2032)
  5. 10.3 China Non - Laboratory - based Cannabis Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Non - Laboratory - based Cannabis Testing Revenue by Application (2027-2032)
  9. 10.5 China Non - Laboratory - based Cannabis Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Non - Laboratory - based Cannabis Testing Revenue (2021-2032)
  2. 11.2 Asia Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Non - Laboratory - based Cannabis Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Non - Laboratory - based Cannabis Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Non - Laboratory - based Cannabis Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Non - Laboratory - based Cannabis Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Non - Laboratory - based Cannabis Testing Revenue by Country
  11. 11.6.1 Asia Non - Laboratory - based Cannabis Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Non - Laboratory - based Cannabis Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Non - Laboratory - based Cannabis Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Non - Laboratory - based Cannabis Testing Revenue (2021-2032)
  2. 12.2 SAMEA Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Non - Laboratory - based Cannabis Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Non - Laboratory - based Cannabis Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Non - Laboratory - based Cannabis Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Non - Laboratory - based Cannabis Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Non - Laboratory - based Cannabis Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Non - Laboratory - based Cannabis Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Non - Laboratory - based Cannabis Testing Revenue by Country
  11. 12.6.1 SAMEA Non - Laboratory - based Cannabis Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Non - Laboratory - based Cannabis Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Non - Laboratory - based Cannabis Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst